University of Leicester
Browse
1-s2.0-S0895435623001609-main.pdf (822.77 kB)

Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review

Download (822.77 kB)
journal contribution
posted on 2023-12-08, 16:28 authored by AM Manyara, P Davies, D Stewart, CJ Weir, AE Young, V Wells, J Blazeby, NJ Butcher, S Bujkiewicz, AW Chan, GS Collins, D Dawoud, M Offringa, M Ouwens, JS Ross, RS Taylor, O Ciani

Objective

To synthesize the current literature on the use of surrogate end points, including definitions, acceptability, and limitations of surrogate end points and guidance for their design/reporting, into trial reporting items.


Study Design and Setting

Literature was identified through searching bibliographic databases (until March 1, 2022) and gray literature sources (until May 27, 2022). Data were thematically analyzed into four categories: (1) definitions, (2) acceptability, (3) limitations and challenges, and (4) guidance, and synthesized into reporting guidance items.


Results

After screening, 90 documents were included: 79% (n = 71) had data on definitions, 77% (n = 69) on acceptability, 72% (n = 65) on limitations and challenges, and 61% (n = 55) on guidance. Data were synthesized into 17 potential trial reporting items: explicit statements on the use of surrogate end point(s) and justification for their use (items 1–6); methodological considerations, including whether sample size calculations were informed by surrogate validity (items 7–9); reporting of results for composite outcomes containing a surrogate end point (item 10); discussion and interpretation of findings (items 11–14); plans for confirmatory studies, collecting data on the surrogate end point and target outcome, and data sharing (items 15–16); and informing trial participants about using surrogate end points (item 17).


Conclusion

The review identified and synthesized items on the use of surrogate end points in trials; these will inform the development of the Standard Protocol Items: Recommendations for Interventional Trials–SURROGATE and Consolidated Standards of Reporting Trials–SURROGATE extensions.

History

Author affiliation

Department of Population Health Sciences, University of Leicester

Version

  • VoR (Version of Record)

Published in

Journal of Clinical Epidemiology

Volume

160

Pagination

83 - 99

Publisher

Elsevier BV

issn

0895-4356

eissn

1878-5921

Copyright date

2023

Available date

2023-12-08

Spatial coverage

United States

Language

eng

Usage metrics

    University of Leicester Publications

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC